Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Medtronic
Merck
Harvard Business School
Colorcon

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Asparaginase - Biologic Drug Details

See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for asparaginase

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Jazz PharmaceuticalsPhase 2/Phase 3
Children's Oncology Group (COG)Phase 2/Phase 3
University Hospital MuensterPhase 3

See all asparaginase clinical trials

Recent Litigation for asparaginase

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Genentech, Inc. v. Pfizer Inc.2019-04-05
Genentech, Inc. v. Immunex Rhode Island Corp.2019-03-29
Genentech, Inc. v. Amgen, Inc.2017-10-18

See all asparaginase litigation

PTAB Litigation
PetitionerDate
Hospira, Inc.2016-09-09

See all asparaginase litigation

Patent Text Search: US Patents for asparaginase

These patents were identified by searching patent claims

Supplementary Protection Certificates for asparaginase

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
35/1996 Austria   Start Trial PRODUCT NAME: PEGYLIERTES LIPOSOMALES DOXORUBICIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES
C018/2007 Ireland   Start Trial SPC018/2007: 20071012, EXPIRES: 20190519
325 Luxembourg   Start Trial PRODUCT NMAE. LUMINITY; REGISTRATION DATE: 20060920
0031 Netherlands   Start Trial 960031, 20101020, EXPIRES: 20110620
07C/027 Belgium   Start Trial PRODUCT NAME: PERFLUTREN; AUTHORISATION NUMBER AND DATE: EU/1/06/361/001 20060922
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.